source
- Roche presents positive Phase 2 results for enicepatide in overweight and obese type 2 diabetes patientsRoche has released new data from a Phase 2 trial of enicepatide, a peptide acquired from Carmot Therapeutics, focusing on overweight or obese adults with type 2 diabetes. The trial met its primary…
- Siemens Healthineers partners with Novo to raise awareness and testing for fatty liver diseaseSiemens Healthineers and Novo have announced a collaboration aimed at increasing awareness and improving diagnosis of metabolic dysfunction-associated steatotic liver disease (MASLD) and its progre…